VEGF-C as a putative therapeutic target in cancer

por Michaelsen, Signe R., Poulsen, Hans S., Hamerlik, Petra
Publicado 2019

The Use of Longitudinal (18)F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts

por Nedergaard, Mette K., Kristoffersen, Karina, Michaelsen, Signe R., Madsen, Jacob, Poulsen, Hans S., Stockhausen, Marie-Thérése, Lassen, Ulrik, Kjaer, Andreas
Publicado 2014

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma

por Kristensen, Lasse S., Michaelsen, Signe R., Dyrbye, Henrik, Aslan, Derya, Grunnet, Kirsten, Christensen, Ib J., Poulsen, Hans S., Grønbæk, Kirsten, Broholm, Helle
Publicado 2016

Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

por Nørøxe, Dorte S., Yde, Christina W., Østrup, Olga, Michaelsen, Signe R., Schmidt, Ane Y., Kinalis, Savvas, Torp, Mathias H., Skjøth‐Rasmussen, Jane, Brennum, Jannick, Hamerlik, Petra, Poulsen, Hans S., Nielsen, Finn C., Lassen, Ulrik
Publicado 2020

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance

por Michaelsen, Signe R, Staberg, Mikkel, Pedersen, Henriette, Jensen, Kamilla E, Majewski, Wiktor, Broholm, Helle, Nedergaard, Mette K, Meulengracht, Christopher, Urup, Thomas, Villingshøj, Mette, Lukacova, Slávka, Skjøth-Rasmussen, Jane, Brennum, Jannick, Kjær, Andreas, Lassen, Ulrik, Stockhausen, Marie-Thérése, Poulsen, Hans S, Hamerlik, Petra
Publicado 2018